Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998
I commend Crouch et al1 on their study, which was published in the September 1997 issue of the ARCHIVES. As the coordinator of a prospective, randomized study that supported the use of aminocaproic acid in the treatment of traumatic hyphema,2 I have been disappointed when ophthalmologists were reluctant to use the drug because of the fear of potential side effects. With this demonstration of the efficacy of topical aminocaproic acid, more physicians may be willing to use it for their patients. However, I have several concerns with the article by Crouch et al.
Fourman S. Topical Aminocaproic Acid in the Treatment of Patients With Traumatic Hyphema. Arch Ophthalmol. 1998;116(3):395-396. doi: